Nature Medicine Study Reveals Abrupt Health Shifts Years Before Menopause
A comprehensive new study published in Nature Medicine reveals that the menopause process triggers abrupt physiological changes across multiple organ systems that can begin more than a decade before the final menstrual period. Researchers analyzed more than 300 million routine healthcare lab records from over one million women in the United States and Israel, collected between 1999 and 2024, to map the biological transition. WELT reported that the research team, led by Uri Alon of the Weizmann Institute of Science, described these widespread shifts as a physiological cliff rather than a gradual decline. A large study describes the menopause as a radical cut in the female body, a kind of cliff.
Menopause Causes Abrupt Alterations in 52 Health Parameters
The analysis identified statistically significant, abrupt alterations in 52 out of 90 evaluated health parameters around the time of menopause, affecting kidney and liver function, blood lipids, bone metabolism, and sexual hormones. Hormonal markers showed shifts long before menstruation ceased entirely. The anti-Müllerian hormone, which indicates ovarian reserve, began a sharper drop approximately 15 years prior to menopause. Bone density declines at an accelerated rate around menopause, elevating risks for osteoporosis. First hormonal changes are already recognizable 15 years before the last period: estrogen and progesterone decrease, while the follicle-stimulating hormone (FSH) increases. Around the follicle-stimulating hormone (FSH), which allows eggs to mature, there was, by contrast, a stronger increase about 14 years before the menopause.
Medical Experts Debate the Physiological Cliff Framing
The characterization of the transition as an abrupt cliff has drawn scrutiny from clinical specialists. Petra Stute, head of a menopause center at a hospital in Bern who was not involved in the research, criticized the term as an overstatement derived from statistically reconstructed population averages rather than direct, individual observations. Kathrin Schaudig, a doctor and hormone expert, echoed these concerns to MDR, noting that clinical practice shows perimenopausal symptoms like joint pain and depression often emerge years before the final period. Peyman Hadji, head of the Hormon- und Osteoporosezentrum in Frankfurt am Main, noted that the large dataset establishes a systemic understanding of menopause. Gynecologists object to the term of the cliff. What women experience after the last period was described by the researchers in the study as a kind of cliff, a “physiological cliff”, meaning a rapid and radical change of the body. In contrast to them, changes ran more gradually.
Low Estrogen Levels Increase Heart Attack Risks
Following the final menstrual period, female estrogen levels remain permanently low throughout postmenopause, a phase lasting a third to half of a woman’s lifetime, according to Heidi Gößlinghoff, a gynecologist, reproductive medicine specialist, and psychotherapist. This sustained estrogen deficiency accelerates muscle mass loss, alters cholesterol profiles, and removes natural cardiovascular protections, driving up heart attack rates. Unaddressed symptoms such as vaginal dryness, sleep disturbances, and recurrent urinary tract infections frequently persist or worsen over time without clinical intervention. During the menopause, the hormone balance fluctuates strongly. Frequently, but not always, the characteristic hot flashes occur, but incontinence, bladder infections, depressive moods, cardiovascular diseases, and osteoporosis can also increase.
Hormone Therapy Weakens Physiological Shifts During Menopause
Patients who underwent hormone therapy experienced weaker and less abrupt physiological shifts across many aspects, according to the Nature Medicine study data. Independent specialists emphasize that while hormone replacement helps manage symptoms, current evidence does not yet warrant broadening preventative prescriptions solely to smooth out lab value transitions. Clinical guidelines in Germany and internationally generally recommend initiating hormone therapy only after menopause is established, following an individual risk-benefit assessment regarding venous thrombosis, stroke, and cancer risks. Therefore, an individual weighing of benefits and risks is necessary. Hormone replacement therapy can help with complaints, but does not come into question for every woman.
Frequently Asked Questions About the Menopause Transition
What specific data sources formed the basis of the Nature Medicine study?
Researchers evaluated more than 300 million routine healthcare lab results gathered from over one million women across the United States between 1999 and 2022 and Israel between 2004 and 2024. The data were based on two independent sources from the USA and Israel.
How early do the first detectable hormonal changes occur before the final period?
The anti-Müllerian hormone drops more sharply about 15 years before menopause, while follicle-stimulating hormone increases roughly 14 years prior, according to the research team led by Uri Alon.
What lifestyle measures do clinicians recommend for managing postmenopausal health?
Gößlinghoff advises patients to maintain regular endurance and strength training, consume adequate amounts of calcium, vitamin D, and protein, and attend preventive examinations.
Large Database Enables Chronological Classification of Body Functions
According to Stute, the strength of the study lies in its large database and an innovative statistical procedure that classifies changes in various body functions chronologically relative to the last menstrual bleed. The phase starts when no further bleeding has occurred for twelve months after the last menstrual period, and subsequently lasts until the end of life. As the expert emphasizes, postmenopause is not simply just the end of the climacteric years, but also the start into a new phase of life.